Evidence map›Paper›PMID 41389796›Full record

ArticleNeuron2026

TDP-43 dysfunction compromises UPF1-dependent mRNA metabolism in ALS.

Francesco Alessandrini, Matthew Wright, Tatsuaki Kurosaki, Olga S Perloff, Marilyn Ngo, Julia K Kofler, Christopher J Donnelly, Lynne E Maquat, Evangelos Kiskinis

Abstract read
In one paragraph

Article in Neuron, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesco AlessandriniThe Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Matthew WrightThe Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Tatsuaki KurosakiDepartment of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA; Center for RNA Biology, University of Rochester, Rochester, NY 14642, USA.
Olga S PerloffThe Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Marilyn NgoDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Julia K KoflerDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Christopher J DonnellyDepartment of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Lynne E MaquatDepartment of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA; Center for RNA Biology, University of Rochester, Rochester, NY 14642, USA.
Evangelos KiskinisThe Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Department of Neuroscience, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: evangelos.kiskinis@northwestern.edu.

Funding

Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
REGULATION OF SELENOPROTEIN RNA METABOLISMR01GM059614 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 1999 to 2022
$9.1M
Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MNDR01NS127187 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELZIL, VERONIQUE, DONNELLY, CHRISTOPHER JAMES · 2021 to 2025
$9.1M
Nonsense-mediated mRNA decay and beyondR35GM149268 · NIGMS · UNIVERSITY OF ROCHESTER · PI Lynne E Maquat · 2023 to 2026
$3.1M
Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease PathophysiologyR01NS134166 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Evangelos Kiskinis, Udai B Pandey · 2023 to 2026
$3.0M
Refining iPSC-Based Spinal Cord Model Systems by Fabricating Developmentally Programmed Extracellular Matrix CuesR01AG086270 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Evangelos Kiskinis · 2024 to 2026
$2.7M
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTDR01NS104219 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISKINIS, EVANGELOS · 2018 to 2022
$2.3M
Defining the Mechanisms by Which Mutations in DNAJC7 Increase Susceptibility to ALS/FTDR21NS131713 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISKINIS, EVANGELOS · 2023 to 2024
$420k
Suppression of Dominant-Negative Transcripts Escaping from Nonsense-Mediated mRNA DecayR21GM147719 · NIGMS · UNIVERSITY OF ROCHESTER · PI KUROSAKI, TATSUAKI · 2022 to 2023
$383k
BLRD VA I01 BX002466NIA NIH HHS P30 AG066468NIA NIH HHS R01 AG086270NIGMS NIH HHS R01 GM059614NIGMS NIH HHS R21 GM147719NIGMS NIH HHS R35 GM149268NINDS NIH HHS R01 NS104219NINDS NIH HHS R01 NS127187NINDS NIH HHS R01 NS134166NINDS NIH HHS R21 NS131713
6 · The paper itself

Abstract

Up-frameshift protein 1 (UPF1)-mediated mRNA decay maintains transcriptome integrity and cellular homeostasis. However, its role in amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by TAR DNA-binding protein 43 (TDP-43) pathology and disrupted mRNA metabolism in motor neurons (MNs), remains unresolved. Here, we integrated RNA sequencing (RNA-seq) after UPF1 knockdown with RNA immunoprecipitation (RIP)-seq of phosphorylated UPF1 to delineate direct UPF1 targets in induced pluripotent stem cell (iPSC)-derived MNs. These transcripts are enriched for autophagy and structurally characterized by GC-rich, long 3' untranslated regions (3' UTRs). UPF1 activity, measured by this transcript signature, is diminished in TDP-43-depleted and ALS patient MNs. Mechanistically, TDP-43 depletion impairs UPF1 phosphorylation; the two proteins interact in an RNA-dependent manner and co-aggregate in pathological inclusions in ALS tissue. Transcriptomic analyses reveal convergent regulation of alternative polyadenylation and 3' UTR length by UPF1 and TDP-43, processes disrupted in ALS models and patient neurons. Our study defines the mRNA surveillance network of UPF1 in MNs and uncovers a link between RNA decay, TDP-43 dysfunction, and ALS neurodegeneration.

Indexed as

Amyotrophic Lateral SclerosisDNA-Binding ProteinsMotor NeuronsRNA HelicasesRNA, MessengerTrans-Activators3' Untranslated RegionsAnimalsHumansInduced Pluripotent Stem CellsPhosphorylation3' Untranslated RegionsDNA-Binding ProteinsRNA HelicasesRNA, MessengerTARDBP protein, humanTrans-ActivatorsUPF1 protein, human3′ UTRALSalternative polyadenylationamyotrophic lateral sclerosisAPAiPSC-derived motor neuronsNMDnonsense-mediated mRNA decayTDP-43UPF1

Identifiers

PMID41389796
PMCPMC12704819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.